Context Optimal management of prostate cancer (PCa) patients with lymph node invasion at
radical prostatectomy and pelvic lymph node dissection still remains unclear. Objective To …

Context The clinical introduction of next-generation imaging methods and molecular
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …

Purpose: Docetaxel represent the standard of care in patients with metastatic, hormone
sensitive prostate cancer. However, androgen receptor axis targeted therapies have also …

Abstract Background and Objectives Prostate-specific membrane antigen (PSMA) positron
emission tomography (PET) combined with computed tomography (CT) is a new imaging …

Objectives To investigate the role of cytoreductive radical prostatectomy in addition to
standard of care for patients with newly diagnosed metastatic prostate cancer. Materials and …

Introduction Terminal differentiation-induced non-coding RNA (TINCR) has been suggested
to have aberrant expression in multiple human cancers, and functions as tumor suppressor …

Purpose STAMPEDE arm H demonstrated a survival benefit for newly diagnosed prostate
cancer (PCa) patients with low metastatic burden (LMB) who additionally received …

Purpose We determine whether the nadir prostate-specific antigen level (PSA nadir) and
time to nadir (TTN) during initial androgen deprivation therapy (ADT) are prognostic factors …

Simple Summary Recent retrospective data indicate a survival benefit of surgical removal of
the prostate in patients with oligometastatic prostate cancer as part of a multimodal …

Purpose Approximately 5% of men were initially diagnosed with (also referred to as de
novo) advanced stage prostate cancer and experience far poorer survival compared to men …